- $2.98bn
- $5.30bn
- $5.22bn
- 82
- 89
- 87
- 98
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,595 | 4,515 | 5,556 | 6,350 | 5,219 |
Cost of Revenue | |||||
Gross Profit | 960 | 915 | 1,093 | 1,285 | 1,146 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 4,218 | 4,210 | 4,971 | 5,754 | 4,613 |
Operating Profit | 377 | 305 | 585 | 596 | 606 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 262 | 186 | 479 | 526 | 495 |
Provision for Income Taxes | |||||
Net Income After Taxes | 194 | 125 | 409 | 389 | 377 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 171 | 109 | 391 | 377 | 359 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 171 | 109 | 391 | 377 | 359 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.75 | 3.61 | 7.06 | 9.4 | 7.43 |
Dividends per Share |